tolvaptan has been researched along with 3-iodobenzylguanidine in 1 studies
| Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (3-iodobenzylguanidine) | Trials (3-iodobenzylguanidine) | Recent Studies (post-2010) (3-iodobenzylguanidine) |
|---|---|---|---|---|---|
| 967 | 172 | 786 | 3,563 | 260 | 1,054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Fujita, T; Fukunami, M; Furukawa, Y; Kawahira, M; Kawai, T; Kawasaki, M; Kayama, K; Kikuchi, A; Kimura, T; Morita, T; Nakamura, J; Sakamoto, D; Seo, M; Tamaki, S; Tamura, Y; Tanabe, K; Ueda, K; Yamada, T; Yamamoto, K | 1 |
1 trial(s) available for tolvaptan and 3-iodobenzylguanidine
| Article | Year |
|---|---|
Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction.
Topics: 3-Iodobenzylguanidine; Heart Failure; Humans; Stroke Volume; Tolvaptan; Ventricular Function, Left | 2020 |